| abstract |
Disclosed herein are heterocyclic piperidine derivative compounds of formula (I), wherein R1, R2, R3, R4, A, X, m and n are as defined in the specification; compositions comprising these compounds, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal). |